Table 1.

Baseline patient characteristics

^*CCRT, Concurrent chemoradiotherapy (temozolomide 75 mg/m²/day×42 days); ^†Adjuvant chemotherapy with 6 monthly cycles (temozolomide 150-200 mg/m²/day for days 1-5 every 28 days); N/A, not analyzed.